STOCK TITAN

VICR (NASDAQ: VICR) insider Patrizio Vincarelli files notice to sell 20,000 shares

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Company: VICR insider filing reports proposed sale of 20,000 shares of Common Stock. The cover row lists an aggregate value of $6,448,200.00 and a reference outstanding figure of 33,863,689 shares as of 06/16/2026. The excerpt shows multiple prior 10b5-1 sales by Patrizio Vincarelli on various dates in 2026.

Positive

  • None.

Negative

  • None.

Insights

Routine insider resale under a trading plan; limited new information.

The filing lists a proposed sale of 20,000 shares and cites multiple prior 10b5-1 sales by Patrizio Vincarelli through the year, with per-trade proceeds shown. The cover row associates the 20,000-share item with $6,448,200.00 and an outstanding figure of 33,863,689 shares as of 06/16/2026.

These items are administrative resale disclosures. Cash-flow treatment and whether the company receives proceeds are not specified in the provided excerpt; subsequent filings would show final settlement details if relevant.

Proposed sale 20,000 shares Cover row listing of securities to be sold
Aggregate value (cover row) $6,448,200.00 Associated with the 20,000-share cover row
Shares outstanding (context) 33,863,689 shares Listed in the same row with date <date>06/16/2026</date>
Prior 10b5-1 trade example 50,000 shares 10b5-1 sale on <date>04/15/2026</date> with proceeds listed
Example prior trade proceeds $9,660,511.00 Gross proceeds for 50,000-share trade on <date>04/15/2026</date>
10b5-1 regulatory
"10b5-1 Sales for PATRIZIO VINCIARELLI 06/15/2026"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
Form 144 regulatory
"Filer Information | 144: Filer Information"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
aggregate value financial
"Common | Morgan Stanley ... | 20000 | 6448200.00"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does VICR's Form 144 disclose about the proposed sale?

The Form 144 lists a proposed sale of 20,000 shares of Common Stock with an aggregate value of $6,448,200.00. It also references an outstanding figure of 33,863,689 shares as of 06/16/2026 and prior 10b5-1 sales by the same insider.

Who conducted the prior sales shown in the excerpt for VICR?

The excerpt shows multiple prior 10b5-1 sales executed by Patrizio Vincarelli on dates throughout 2026, with individual trade sizes and gross proceeds listed for each trade in the filing excerpt.

Does the filing state whether proceeds go to the company or the seller?

The provided excerpt does not state who receives proceeds. The rows itemize trade sizes and gross proceeds for resale transactions, but cash‑flow treatment is not specified in this excerpt.

How large is the proposed sale relative to shares outstanding shown here?

The proposed sale of 20,000 shares is small relative to the listed outstanding figure of 33,863,689 shares as of 06/16/2026. The filing excerpt presents both numbers but does not draw conclusions about dilution or impact.